Practice 10

Question 1

Which of the following has a precaution for women to avoid contact with crushed/broken tablets due to risk of absorption through the skin.

1. Finasteride
2. Spironolactone
3. Doxazosin
4. Warfarin

Answer 1

Finasteride

Question 2

CYP 2C9 is involved in metabolizing Plavix into its active form, poor CYP 2C9 metabolizers may be at higher risk of treatment failure. T/F

Answer 2

False

It is 2C19 not 2C9

Question 3

Which of the following are safety monitoring parameters for doxazosin? SATA

1. Floppy Iris Syndrome
2. Daily weights
3. Ototoxicity
4. Orthostatic hypotension

Answer 3

Floppy iris syndrome

Orthostatic hypotension

Question 4

Which of the following are safety monitoring parameters for Spironolactone? SATA

1. Gynecomastia
2. Ototoxicity
3. Serum potassium
4. Serum creatinine

Answer 4

Gynecomastia
Serum potassium
Serum creatinine

Question 5

Which of the following are safety monitoring parameters for dipyridamole and aspirin? SATA

1. Dyspepsia
2. INR
3. Platelet
4. Abdominal pain

Answer 5

Dyspepsia
Platelet
Abdominal pain

Question 6

Warfarin inhibits the synthesis of vitamin K dependent clotting factors II, VII, IX, and X. T/F

Answer 6

True

Question 7

Clopidogrel is a prodrug that must be metabolized by the liver to its inactive form. T/F

Answer 7

False

Active form

Question 8

Which of the following is NOT a common adverse effect from use of Aggrenox?

1. Dehydration
2. Headache
3. Dyspepsia
4. Abdominal pain

Answer 8

Dehydration

Question 9

Which of the following is a common adverse effect from the use of Plavix?

1. Bleeding
2. Electrolyte depletion
3. Hyperuricemia
4. Dehydration

Answer 9

Bleeding

Question 10

Which of the following is not a common adverse effect from use of bumetanide?

1. Azotemia
2. Electrolyte depletion
3. Dehydration
4. Bradycardia

Answer 10

Bradicardia